Market Introduction
Brain aneurysm refers to the development of a bulge in a blood vessel in the brain. This bulging puts pressure on the nerves or brain tissues. It may rupture or can cause brain hemorrhage, resulting in the death of the patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The brain aneurysm treatment market is expected to witness huge growth due to increasing awareness and growing prevalence ofbrain aneurysm. However, the high cost of surgical treatment may hinder the growth of market.
Market Overview and Dynamics
The Asia Pacific brain aneurysm treatmentmarket is projectedto reach US$ 1,737.32millionby2027 from US$ 576.71millionin 2019. The market is anticipated to grow with a CAGR of 14.9% from 2020 to 2027. Factors driving the market growth include increasing research activities, increasing prevalence of brain aneurysm, and increasing number of product launches. However, the high cost of procedures is likely to have a negative impact on the market growth.
Key Market Segments
Based ontype, the medicationsegment accounted for a largershare ofthe Asia Pacificbrain aneurysm treatment market in 2019. In terms of application, the unruptured aneurysm segment held a largershare of the brain aneurysm treatment market in Asia Pacific. Based on enduser, the hospitals segment held the most significant market share of the Asia Pacific brain aneurysm treatment marketin 2019.
Major Sources and Companies Listed
A few major primary and secondary sources referred towhile preparing the Asia Pacific brain aneurysm treatment market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.
Reasons to buy the report
ASIA PACIFIC BRAIN ANEURYSM TREATMENT MARKET SEGMENTATION
By Type
By Condition
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 576.71 Million |
| Market Size by 2027 | US$ 1,737.32 Million |
| CAGR (2020 - 2027) | 14.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Brain Aneurysm Treatment Market is valued at US$ 576.71 Million in 2019, it is projected to reach US$ 1,737.32 Million by 2027.
As per our report Asia Pacific Brain Aneurysm Treatment Market, the market size is valued at US$ 576.71 Million in 2019, projecting it to reach US$ 1,737.32 Million by 2027. This translates to a CAGR of approximately 14.9% during the forecast period.
The Asia Pacific Brain Aneurysm Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Brain Aneurysm Treatment Market report:
The Asia Pacific Brain Aneurysm Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Brain Aneurysm Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Brain Aneurysm Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)